Literature DB >> 2196165

Rational treatment of acid-base disorders.

M L McLaughlin1, J P Kassirer.   

Abstract

Acid-base derangements are encountered frequently in clinical practice and many have life-threatening implications. Treatment is dependent on correctly identifying the acid-base disorder and, whenever possible, repairing the underlying causal process. Bicarbonate is the agent of choice for the treatment of acute metabolic acidosis. Controversy surrounds the use of alkali therapy in lactic acidosis and diabetic ketoacidosis, but bicarbonate should clearly be administered for severe acidosis. In most patients with mild to moderate chloride-responsive metabolic alkalosis, providing an adequate amount of a chloride salt will restore acid-base balance to normal over a matter of days. In contrast, therapy of the chloride-resistant metabolic alkalosis is best directed at the underlying disease. When alkalemia is severe, administering hydrochloric acid or a hydrochloric acid precursor may be necessary. Treatment of respiratory acidosis should be targeted at restoring ventilation; alkali should be administered only for superimposed metabolic acidosis. The therapy of respiratory alkalosis is centred on reversal of the root cause; short of this goal, there is no effective treatment of primary hypocapnia. The coexistence of more than one acid-base disorder (i.e. a mixed disorder) is not uncommon. When plasma bicarbonate concentration and arterial carbon dioxide tension (paCO2) are altered in opposite directions, extreme shifts in pH may occur. In such cases, it is imperative that the nature of the disturbance is identified early and therapy directed at both disorders.

Entities:  

Mesh:

Year:  1990        PMID: 2196165     DOI: 10.2165/00003495-199039060-00003

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  24 in total

1.  Bicarbonate therapy in severe diabetic ketoacidosis.

Authors:  L R Morris; M B Murphy; A E Kitabchi
Journal:  Ann Intern Med       Date:  1986-12       Impact factor: 25.391

2.  Bartter's syndrome: urinary prostaglandin E-like material and kallikrein; indomethacin effects.

Authors:  P V Halushka; H Wohltmann; P J Privitera; G Hurwitz; H S Margolius
Journal:  Ann Intern Med       Date:  1977-09       Impact factor: 25.391

Review 3.  Serum potassium in lactic acidosis and ketoacidosis.

Authors:  M Fulop
Journal:  N Engl J Med       Date:  1979-05-10       Impact factor: 91.245

4.  Lactic acidosis.

Authors:  N E Madias
Journal:  Kidney Int       Date:  1986-03       Impact factor: 10.612

5.  Treatment of ethylene glycol poisoning with intravenous 4-methylpyrazole.

Authors:  F J Baud; M Galliot; A Astier; D V Bien; R Garnier; J Likforman; C Bismuth
Journal:  N Engl J Med       Date:  1988-07-14       Impact factor: 91.245

6.  Extreme hypocapnia in the critically ill patient.

Authors:  J T Mazzara; S M Ayres; W J Grace
Journal:  Am J Med       Date:  1974-04       Impact factor: 4.965

7.  Alkalosis resulting from combined administration of a "nonsystemic" antacid and a cation-exchange resin.

Authors:  E T Schroeder
Journal:  Gastroenterology       Date:  1969-05       Impact factor: 22.682

Review 8.  Management of diabetic ketoacidosis.

Authors:  T H Sanson; S N Levine
Journal:  Drugs       Date:  1989-08       Impact factor: 9.546

9.  Life-threatening hyperkalemia induced by arginine.

Authors:  D A Bushinsky; F J Gennari
Journal:  Ann Intern Med       Date:  1978-11       Impact factor: 25.391

10.  Treatment of alcoholic acidosis: the role of dextrose and phosphorus.

Authors:  P D Miller; R E Heinig; C Waterhouse
Journal:  Arch Intern Med       Date:  1978-01
View more
  1 in total

Review 1.  Acid-base disorders in the critically ill child.

Authors:  R Munoz; J P Guzman
Journal:  Indian J Pediatr       Date:  1993 May-Jun       Impact factor: 1.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.